Levetiracetam Improves Survival in Diffuse Midline Glioma by Targeting GABAergic Synapses
Published in Nature Medicine, new research reveals that the common antiseizure medication levetiracetam significantly reduces tumor growth and extends survival in diffuse midline glioma (DMG) by selectively dampening GABAergic synaptic … Read More